PGNX

Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC

[at noodls] – – Outcomes From Clinical Study in Prostate Cancer Presented at Genitourinary Cancers Symposium – TARRYTOWN, N.Y., Feb. 14, 2013 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today reported … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Progenics is hiring next, click here to view […]

Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline

[at noodls] – – Gains Therapeutic and Diagnostic Compounds That Deepen Strategic Focus on PSMA Target – – Adds Late-Stage Ultra-Orphan Oncology Candidate – TARRYTOWN, N.Y., Jan. 22, 2013 (GLOBE NEWSWIRE) — Progenics … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboardSee who Progenics is hiring next, click here to view […]

Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock

[at noodls] – TARRYTOWN, N.Y., Nov. 28, 2012 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today that it is offering to sell, subject to market and other conditions, shares of its common … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Positive Naloxegol Results; NKTR Powering Through Analyst Downgrade

[ACN Newswire] – By David MoskowitzNektar Therapeutics (NASDAQ:NKTR) hosted a conference call Monday morning, highlighting the successful results from two Phase III trials and one safety extension study for Naloxegol, … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboard […]

Progenics Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference

[at noodls] – Progenics Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference TARRYTOWN, N.Y., Nov. 6, 2012 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) chief executive officer … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboard […]

Progenics Pharmaceuticals to Host Conference Call to Review Third Quarter Financial Results on November 8

[at noodls] – Progenics Pharmaceuticals to Host Conference Call to Review Third Quarter Financial Results on November 8 TARRYTOWN, N.Y., Nov. 2, 2012 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) … moreView todays social media effects on PGNXView the latest stocks trending across Twitter. Click to view dashboard […]